Back
Ultragenyx Pharmaceutical Vs. Anterix Industry Stock Comparison
Sell
46
RARE
Ultragenyx Pharmaceutical
Last Price:
56.57
Seasonality Move:
7.55%
Buy
60
ATEX
Anterix
Last Price:
37.06
Seasonality Move:
2.68%
Sell
46
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $56.56. The Score for RARE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Anterix (ATEX)
is a Buy
Is Anterix a Buy, Sell or Hold?
- The current Anterix [ATEX] share price is $37.12. The Score for ATEX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ATEX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $56.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
ATEX Stock Price Chart
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.6 | Buy |
| Relative Strength Index (14 RSI): | 53.19 | Buy |
| Chaikin Money Flow: | 285053 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.65 - 58.23) | Sell |
| Bollinger Bands (100): | (40.36 - 54.44) | Buy |
ATEX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 43 | Sell |
| Chaikin Money Flow: | -25930 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.04 - 38.84) | Sell |
| Bollinger Bands (100): | (33.07 - 39.75) | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.53 | Buy |
| 20-day SMA: | 56.94 | Sell |
| 50-day SMA: | 53.49 | Buy |
| 200-day SMA: | 47 | Buy |
| 8-day EMA: | 56.35 | Buy |
| 20-day EMA: | 56.39 | Buy |
| 50-day EMA: | 53.6 | Buy |
| 200-day EMA: | 47.49 | Buy |
ATEX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.15 | Sell |
| 20-day SMA: | 37.98 | Sell |
| 50-day SMA: | 37.98 | Sell |
| 200-day SMA: | 34.84 | Buy |
| 8-day EMA: | 37.98 | Sell |
| 20-day EMA: | 37.96 | Sell |
| 50-day EMA: | 37.63 | Sell |
| 200-day EMA: | 35.51 | Buy |
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Anterix Earnings Growth & ATEX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.17 per share, and a decrease next year of $2.65 per share.
Ultragenyx Pharmaceutical Technical Analysis
| Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Anterix Technical Analysis
| Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||